Pharma Journalist - Page 904 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA accepts Intellipharmaceutics’ NDA for Rexista to treat moderate to severe pain

Momenta announces FDA warning letter to contracted Glatopa’s fill/finish manufacturer

Arix Bioscience raises £100m in IPO

Health Canada Approves Otsuka and Lundbeck’s REXULTI

Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery

Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility

Takeda acquires Ariad Pharmaceuticals

Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement for episil

Mayne Pharma Launches Butalbital Acetaminophen Tablets in The United States

X-Chem Expands Collaboration with Janssen in Inflammatory Diseases